Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Ioflupane I-123

Next Previous
Drug Profile

Ioflupane I-123

Alternative Names: DaTSCAN; DaTscan; Ioflupane (123I); Radio-labelled ioflupane; β-CIT-FP

Latest Information Update: 11 Apr 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator GE Healthcare
  • Class Diagnostic agents; Nortropanes; Small molecules
  • Mechanism of Action Single-photon emission-computed tomography enhancers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Dementia; Lewy body disease; Multiple system atrophy; Parkinsonian disorders; Progressive supranuclear palsy
  • No development reported Essential tremor; Parkinson's disease

Most Recent Events

  • 31 Mar 2025 Nihon Medi-Physics has been acquired by GE Healthcare
  • 03 Dec 2024 No development reported - Phase-III for Essential tremor (Diagnosis) in China (IV)
  • 03 Dec 2024 No development reported - Phase-III for Multiple system atrophy (Diagnosis) in China (IV)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top